Features of transbronchial tuberculous mediastinal lymphadenitis and a study on bronchoscopic interventional therapy
SU Duo-hua;TANG Chun-mei;ZHANG Yan-bin;FANG Qiong;XIE Yi-kai;XIAO Hai-hao;Guangzhou Chest Hospital;
Objective To explore the clinical features of transbronchial tuberculous mediastinal lymphadenitis and value of bronchoscopic interventional therapy. Methods The clinical data of 50 patients who had been diagnosed as tuberculous mediastinal lymphadenitis and had received bronchoscopic interventional therapy in our hospital during the period from January 2008 to January 2013 were retrospectively analyzed. The bronchoscopic change, improvement in symptoms, and time to sputum smear and culture conversion were used to assess the therapeutic effect. The patients were followed up for six months. Results The mean age of the patients was(35 ±15) years and the male to female ratio was 1:1.2. The lesions occurred mostly at the right middle lobe in 24%(12 /50) of the patients. The total effectiveness rate was up to 98%(49 / 50) after chemotherapy and bronchoscopic interventional therapy. The major complication associated with interventional therapy was hemoptysis(8%, 4 / 50).After follow-up of 6 months, 49 patients with active lesions were stable, with smooth bronchial mucosa and no obvious obstruction by granulation and caseous necrosis tissues. Conclusions The relavent clinical symptoms of transbronchial tuberculous mediastinal lymphadenitis is mainly caused by tuberculosis inflammation which destroys and blocks the airway. The fiber bronchoscopic therapy with forceps clip and drug infusion has a definite effect and fewer complications.
【CateGory Index】： R523